Yuxuan Hu1, Viatcheslav Gurev1, Jason Constantino1, Natalia Trayanova2. 1. Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland. 2. Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland. Electronic address: ntrayanova@jhu.edu.
Abstract
BACKGROUND: Cardiac resynchronization therapy (CRT) has been demonstrated to lead to restoration of oxygen consumption homogeneity throughout the left ventricle (LV), which is important for long-term reverse remodeling of the ventricles. However, research has focused exclusively on identifying the LV pacing sites that led to acute hemodynamic improvements. It remains unclear whether there exist LV pacing sites that could both improve the hemodynamics and result in ATP consumption homogeneity throughout the LV, thus maximizing both CRT short-term and long-term benefits. OBJECTIVE: The purpose of this study was to demonstrate the feasibility of optimizing CRT pacing locations to achieve maximal improvement in both ATPCTHI (an ATP consumption heterogeneity index) and stroke work. METHODS: We used an magnetic resonance image-based electromechanical model of the dyssynchronous heart failure (DHF) canine ventricles. ATPCTHI and stroke work improvement were determined for each of 34 CRT pacing sites evenly spaced over the LV epicardium. RESULTS: Results demonstrated the feasibility of determining the optimal LV pacing site that achieves simultaneous maximum improvements in ATPCTHI and stroke work. The optimal LV CRT pacing sites in the DHF canine ventricles were located midway between apex and base. The improvement in ATPCTHI decreased more rapidly with the distance from the optimal sites compared to stroke work improvement. CRT from the optimal sites homogenized ATP consumption by increasing septal ATP consumption and decreasing that of the lateral wall. CONCLUSION: Simulation results using a canine heart failure model demonstrated that CRT can be optimized to achieve improvements in both ATPCTHI and stroke work.
BACKGROUND: Cardiac resynchronization therapy (CRT) has been demonstrated to lead to restoration of oxygen consumption homogeneity throughout the left ventricle (LV), which is important for long-term reverse remodeling of the ventricles. However, research has focused exclusively on identifying the LV pacing sites that led to acute hemodynamic improvements. It remains unclear whether there exist LV pacing sites that could both improve the hemodynamics and result in ATP consumption homogeneity throughout the LV, thus maximizing both CRT short-term and long-term benefits. OBJECTIVE: The purpose of this study was to demonstrate the feasibility of optimizing CRT pacing locations to achieve maximal improvement in both ATPCTHI (an ATP consumption heterogeneity index) and stroke work. METHODS: We used an magnetic resonance image-based electromechanical model of the dyssynchronous heart failure (DHF) canine ventricles. ATPCTHI and stroke work improvement were determined for each of 34 CRT pacing sites evenly spaced over the LV epicardium. RESULTS: Results demonstrated the feasibility of determining the optimal LV pacing site that achieves simultaneous maximum improvements in ATPCTHI and stroke work. The optimal LV CRT pacing sites in the DHFcanine ventricles were located midway between apex and base. The improvement in ATPCTHI decreased more rapidly with the distance from the optimal sites compared to stroke work improvement. CRT from the optimal sites homogenized ATP consumption by increasing septal ATP consumption and decreasing that of the lateral wall. CONCLUSION: Simulation results using a canineheart failure model demonstrated that CRT can be optimized to achieve improvements in both ATPCTHI and stroke work.
Authors: William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: Angelo Auricchio; Christoph Stellbrink; Stefan Sack; Michael Block; Jürgen Vogt; Patricia Bakker; Christof Huth; Friedrich Schöndube; Ulrich Wolfhard; Dirk Böcker; Olaf Krahnefeld; Hans Kirkels Journal: J Am Coll Cardiol Date: 2002-06-19 Impact factor: 24.094
Authors: Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245
Authors: S Cazeau; C Leclercq; T Lavergne; S Walker; C Varma; C Linde; S Garrigue; L Kappenberger; G A Haywood; M Santini; C Bailleul; J C Daubert Journal: N Engl J Med Date: 2001-03-22 Impact factor: 91.245
Authors: Robert H Helm; Melissa Byrne; Patrick A Helm; Samantapudi K Daya; Nael F Osman; Richard Tunin; Henry R Halperin; Ronald D Berger; David A Kass; Albert C Lardo Journal: Circulation Date: 2007-02-12 Impact factor: 29.690
Authors: Oliver Lindner; Jens Sörensen; Jürgen Vogt; Eva Fricke; Detlev Baller; Dieter Horstkotte; Wolfgang Burchert Journal: J Nucl Med Date: 2006-03 Impact factor: 10.057
Authors: Ole A Breithardt; Christoph Stellbrink; Lieven Herbots; Piet Claus; Anil M Sinha; Bart Bijnens; Peter Hanrath; George R Sutherland Journal: J Am Coll Cardiol Date: 2003-08-06 Impact factor: 24.094
Authors: A Prakosa; P Malamas; S Zhang; F Pashakhanloo; H Arevalo; D A Herzka; A Lardo; H Halperin; E McVeigh; N Trayanova; F Vadakkumpadan Journal: Prog Biophys Mol Biol Date: 2014-08-19 Impact factor: 3.667
Authors: Pablo Lamata; Ramón Casero; Valentina Carapella; Steve A Niederer; Martin J Bishop; Jürgen E Schneider; Peter Kohl; Vicente Grau Journal: Prog Biophys Mol Biol Date: 2014-08-10 Impact factor: 3.667